Med Ed 101
JULY 7, 2024
JS is a 45 year-old male who has been taking bupropion SR 150 mg twice daily for about 4 weeks. He has been taking it for depression. He reports that depressive symptoms have started to improve but he does notice that he has a harder time getting to sleep and staying asleep since beginning the […] The post Wellbutrin XL Versus Bupropion SR – Insomnia Rates appeared first on Med Ed 101.
Express Pharma
JULY 7, 2024
Season 2 of the Express Pharma – Nutrify Today Boardroom series presents key dialogues from the Nutrify C Suite Sumflex 2024, held over June 6-7, 2024. In this video, industry leaders dissect the trends impacting the Vitamins, Minerals and Supplements (VMS) segment in India’s Pharma market, ranging from the focus shift from illness to wellness, emerging segments like sports nutrition, sleep products, increasing regulator oversight requiring evidence based nutraceuticals, and future innovat
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JULY 7, 2024
Novartis, Pfizer, Otsuka and Novo Nordisk have been called out for breaching the ABPI code of practice
Express Pharma
JULY 7, 2024
OnabotulinumtoxinA (BoNT-A) and monoclonal antibodies against the calcitonin gene-related protein (anti-CGRP mAbs) have emerged as the first disease-specific preventative treatments to be approved for chronic migraine. At the 10th Congress of the European Academy of Neurology (EAN) 2024, Danilo Antonio Montisano, MD, presented real-world evidence findings from a retrospective, observational multicenter cohort study (RAMO) comparing the effectiveness of anti-CGRP mAbs and BoNT-A for chronic migra
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
FDA Law Blog: Biosimilars
JULY 7, 2024
By Gail H. Javitt — In its final rule on laboratory developed tests (LDTs) (see our prior blog here ), FDA acknowledged that “some laboratories may lack familiarity, experience, or existing infrastructure for complying with FDA requirements” and made multiple references to a “small entity compliance guidance” that the agency intended to publish to “provide additional guidance to small businesses.
Drug Patent Watch
JULY 7, 2024
This chart shows the drugs with the most patents in France. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Drug Patent Watch
JULY 7, 2024
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.
Pharmacy Times
JULY 7, 2024
In the 2 mg bulevirtide (Gilead Sciences) group, 44% of individuals achieved HDV RNA that was undetectable compared with 70% in the 10 mg group.
Expert insights. Personalized for you.
105 
Let's personalize your content